CVD

Rivaroxaban decreased VTE rate in high-risk orthopedic joint surgery patients

Rivaroxaban decreased VTE rate in high-risk orthopedic joint surgery patients

By

Researchers developed a protocol to demonstrate the efficacy of rivaroxaban in lowering the risk of venous thromboembolism among orthopedic joint surgery patients.

Sign Up for Free e-newsletters